| Establishing the clinical benefits of in-hospital or pre-admission use of statins in patients with coronavirus disease 2019 (COVID-19) would have significant clinical implications; where statin treatment is appropriately indicated, clinicians should ensure patients are receiving statins with appropriate intensity. |
| The use of statins was associated with a significantly lower risk of all-cause mortality and the composite endpoint of severe illness in patients with COVID-19 compared to non-use of statins. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.